Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project

BACKGROUND: Polypharmacy of additional psychotropics alongside the main treatment drug (antipsychotics in schizophrenia and antidepressants in major depressive disorder) is common in Japan. Our goal is to align psychotropic prescription in Japan with international standards, while reducing the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Naoki, Yasui-Furukori, Norio, Hasegawa, Naomi, Ishikawa, Shuhei, Hori, Hikaru, Iida, Hitoshi, Ichihashi, Kayo, Miura, Kenichiro, Matsumoto, Junya, Numata, Shusuke, Kodaka, Fumitoshi, Furihata, Ryuji, Ohi, Kazutaka, Ogasawara, Kazuyoshi, Iga, Jun-ichi, Muraoka, Hiroyuki, Komatsu, Hiroshi, Takeshima, Masahiro, Atake, Kiyokazu, Kido, Mikio, Nakamura, Toshinori, Kishimoto, Taishiro, Hishimoto, Akitoyo, Onitsuka, Toshiaki, Okada, Tsuyoshi, Ochi, Shinichiro, Nagasawa, Tatsuya, Makinodan, Manabu, Yamada, Hiroki, Tsuboi, Takashi, Yamada, Hisashi, Inada, Ken, Watanabe, Koichiro, Hashimoto, Ryota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308621/
https://www.ncbi.nlm.nih.gov/pubmed/37380997
http://dx.doi.org/10.1186/s12888-023-04908-4

Ejemplares similares

Ejemplares similares